Your session is about to expire
← Back to Search
Sun Protection for Surgical Scar Healing
N/A
Recruiting
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patient is scheduled for a cutaneous excisional surgical procedure
Surgery performed on sunlight-exposed anatomical regions (head, face, neck, hairless scalp)
Must not have
Patient unwilling to return for 3-month follow-up
Patient is < 18 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether sun protection affects the appearance of scars after surgery to repair defects from Mohs micrographic surgery.
Who is the study for?
This trial is for adults over 18 who are having skin surgery in sun-exposed areas like the head, face, or neck. They must be able to consent and come back for a follow-up. It's not for pregnant individuals, prisoners, those under 18, anyone unwilling to return after 3 months, people allergic to zinc sunscreen, or with collagen vascular disease.
What is being tested?
The study tests if zinc sunscreen affects how surgical scars heal and look after Mohs surgery. It's a split-wound trial where one part of the scar gets sunscreen and the other doesn't. After three months, they'll check scar appearance using special scales and instruments.
What are the potential side effects?
Possible side effects may include reactions at the site where the sunscreen is applied on half of the wound such as redness or irritation; however specific side effects will be monitored throughout the study.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am scheduled for a skin surgery to remove tissue.
Select...
I had surgery on parts of my body that are often exposed to the sun.
Select...
I am 18 years old or older.
Select...
My skin wound was stitched up in a straight line.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am unwilling or unable to return for a follow-up in 3 months.
Select...
I am under 18 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3-12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Patient observer assessment score (POSAS)
Secondary study objectives
Colorimeter measurement of wound vascularity and hyperpigmentation.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Sunscreen ApplicationExperimental Treatment1 Intervention
The study participant will be instructed to start applying the sunscreen provided to them to the randomly assigned half of the wound (A or B).
Group II: No Suncreen ApplicationExperimental Treatment1 Intervention
The study participant will be instructed to not apply the sunscreen provided to them to the randomly assigned half of the wound (A or B).
Find a Location
Who is running the clinical trial?
University of California, DavisLead Sponsor
943 Previous Clinical Trials
4,755,638 Total Patients Enrolled
5 Trials studying Surgical Wound
233 Patients Enrolled for Surgical Wound
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I had surgery on parts of my body that are often exposed to the sun.I am unwilling or unable to return for a follow-up in 3 months.I am 18 years old or older.My skin wound was stitched up in a straight line.I am scheduled for a skin surgery to remove tissue.I am under 18 years old.I am willing to come back for follow-up visits.
Research Study Groups:
This trial has the following groups:- Group 1: Sunscreen Application
- Group 2: No Suncreen Application
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger